These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25465716)

  • 1. Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas.
    Wu H; Bui MM; Leston DG; Shao H; Sokol L; Sotomayor EM; Zhang L
    BMC Cancer; 2014 Dec; 14():900. PubMed ID: 25465716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience.
    Wu H; Zhang L; Shao H; Sokol L; Sotomayor E; Letson D; Bui MM
    Br J Haematol; 2014 Jul; 166(1):60-8. PubMed ID: 24673481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).
    Messina C; Ferreri AJ; Govi S; Bruno-Ventre M; Gracia Medina EA; Porter D; Radford J; Heo DS; Park HY; Pro B; Jayamohan J; Visco C; Scarfò L; Zucca E; Gospodarowicz M; Christie D;
    Br J Haematol; 2014 Mar; 164(6):834-40. PubMed ID: 24383942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and outcomes of 31 patients with primary bone lymphoma].
    Zhu Y; Yue C; Wu B; Ping B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Mar; 33(3):444-7. PubMed ID: 23529250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study.
    Maruyama D; Watanabe T; Beppu Y; Kobayashi Y; Kim SW; Tanimoto K; Makimoto A; Kagami Y; Terauchi T; Matsuno Y; Tobinai K
    Jpn J Clin Oncol; 2007 Mar; 37(3):216-23. PubMed ID: 17472971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Park MJ; Park SH; Park PW; Seo YH; Kim KH; Seo JY; Jeong JH; Kim MJ; Ahn JY; Hong J
    J Clin Pathol; 2015 Sep; 68(9):733-8. PubMed ID: 25998512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Bone Lymphoma: A Clinical Analysis of 17 Patients in a Single Institution.
    Hayase E; Kurosawa M; Suzuki H; Kasahara K; Yamakawa T; Yonezumi M; Suzuki S; Teshima T
    Acta Haematol; 2015; 134(2):80-5. PubMed ID: 25895753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study.
    Takahashi H; Sakai R; Sakuma T; Matsumura A; Miyashita K; Ishii Y; Nakajima Y; Numata A; Hattori Y; Miyazaki T; Hashimoto C; Koharazawa H; Takemura S; Taguchi J; Fujimaki K; Fujita H; Nakajima H
    Indian J Hematol Blood Transfus; 2021 Jan; 37(1):60-66. PubMed ID: 33707836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast.
    Seker M; Bilici A; Ustaalioglu BO; Yilmaz B; Ozturk B; Ünal A; Dane F; Ozdemir NY; Elkiran ET; Kalender ME; Gumus M; Benekli M
    Arch Gynecol Obstet; 2011 Aug; 284(2):405-9. PubMed ID: 20872226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
    Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
    J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphomas of the bone: a pathological and clinical study of 54 cases.
    Gianelli U; Patriarca C; Moro A; Ponzoni M; Giardini R; Massimino M; Alfano RM; Armiraglio E; Nuciforo P; Bosari S; Coggi G; Parafioriti A
    Int J Surg Pathol; 2002 Oct; 10(4):257-66. PubMed ID: 12490975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
    Beal K; Allen L; Yahalom J
    Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases.
    Zhao XF; Young KH; Frank D; Goradia A; Glotzbecker MP; Pan W; Kersun LS; Leahey A; Dormans JP; Choi JK
    Am J Clin Pathol; 2007 Jan; 127(1):47-54. PubMed ID: 17145622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.
    Song MK; Yang DH; Lee GW; Lim SN; Shin S; Pak KJ; Kwon SY; Shim HK; Choi BH; Kim IS; Shin DH; Kim SG; Oh SY
    Leuk Res; 2016 Mar; 42():1-6. PubMed ID: 26851438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors.
    Adams H; Tzankov A; d'Hondt S; Jundt G; Dirnhofer S; Went P
    Hum Pathol; 2008 Sep; 39(9):1323-30. PubMed ID: 18614198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.